Bristol-Myers Squibb Company (NYSE: BMY)

Bristol-Myers Squibb Company (NYSE: BMY) operates discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases.

It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. 

The company is best known for its rheumatoid arthritis medication Orencia, a hepatitis B medication called Baraclude, its HIV antiviral drug Reyataz and cancer drug Opdivo.

In addition, Bristol-Myers Squibb has a growing list of blockbuster therapies in the oncology and cardiovascular space.

With a rich product pipeline, a dividend yield of 2.85%, and forward-year price-to-earnings ratio below 10, this large cap healthcare stock is an ideal selection for helping investors protect and grow their wealth in both rising and falling markets.